Candida Albicans Antibodies

Blood

Report in 720Hrs

At Home

No Fasting Required

Details

Detects antibodies to Candida albicans.

₹15,614₹22,306

30% OFF

Candida Albicans Antibodies - Comprehensive Test Guide

Section 1: Why is it done?
- Test Purpose: Detects antibodies (IgG, IgM, and IgA) produced by the immune system in response to Candida albicans infection; helps identify current or past candidal infections
- Primary Indications: Diagnosis of systemic candidiasis or invasive candidal infections; evaluation of recurrent vaginal or oral thrush; assessment of persistent fungal infections in immunocompromised patients
- Clinical Circumstances: When patients present with suspected disseminated candidal infection; during investigation of fever of unknown origin with risk factors for candidiasis; monitoring immunocompromised patients (HIV/AIDS, transplant recipients, chemotherapy patients); evaluation of chronic mucosal candidiasis; suspected candidal bloodstream infections
- Timing: Typically performed when clinical symptoms suggest candidal infection; IgM antibodies indicate acute infection (early response); IgG antibodies indicate past exposure or chronic infection; testing performed at any time, though sensitivity may vary with infection stage
Section 2: Normal Range
- Reference Ranges: Negative (<0.9 Index/Ratio or <0.8 in some labs); Borderline (0.9-1.1 Index/Ratio); Positive (>1.1 Index/Ratio or >1.0-1.3 depending on assay)
- Interpretation Guide: Negative/Normal: No significant antibodies detected; indicates no recent infection or no immune response to Candida albicans; possible in healthy individuals or those without active infection
- Borderline Results: Equivocal results requiring retesting; may indicate early infection, past exposure, or non-specific reactions; clinical correlation necessary; repeat testing recommended in 1-2 weeks
- Positive Results: Antibodies detected indicating current or past Candida albicans infection; supports diagnosis of candidiasis; high titers more suggestive of acute or disseminated infection
- Units of Measurement: Index or Ratio values (typically 0-10 scale); some laboratories use International Units (IU/mL); semiquantitative measurements based on enzyme immunoassay (EIA)
- Normal vs. Abnormal Meaning: Normal (Negative) suggests absence of significant candidal infection or no immune response; Abnormal (Positive) indicates immune response to Candida, suggesting active, recent, or chronic infection; must be interpreted with clinical presentation and culture results
Section 3: Interpretation
- IgM Antibodies (Acute Infection Marker): Positive IgM indicates recent or acute Candida albicans infection; typically appears early in infection (3-7 days); suggests active immune response to primary infection; declines within weeks if infection resolves
- IgG Antibodies (Chronic/Past Infection Marker): Positive IgG indicates past or chronic Candida infection; appears later in infection course (10-14 days); may remain elevated for months to years; can indicate immunity or history of exposure
- IgA Antibodies (Mucosal Infection Marker): Positive IgA suggests mucosal candidiasis or gastrointestinal tract infection; indicates local immune response; particularly useful in oral thrush or esophageal candidiasis evaluation
- High Antibody Titers: Significantly elevated levels suggest disseminated or systemic candidiasis; indicate more severe infection or persistent exposure; correlation with clinical symptoms essential; may indicate complications or poor infection control
- Factors Affecting Results: Immunosuppression (may produce false negatives); timing of test relative to infection onset; presence of other fungal infections (cross-reactivity); prior candidal exposure or colonization; antibiotic use affecting normal flora; laboratory variation in testing methods
- Clinical Significance of Patterns: IgM + IgG positive: Acute infection superimposed on chronic candidiasis; IgG only positive: Past or chronic infection; IgM + IgG negative: Unlikely candidal infection or very early disease; Rising IgG titers on serial testing: Active or worsening infection; Discordant results: May require culture confirmation or imaging
- Limitations: Sensitivity not 100%; may be negative in severe immunosuppression (AIDS with CD4<50); cannot distinguish between colonization and infection; regional variations in antibody prevalence; some healthy individuals may have low-positive results
Section 4: Associated Organs
- Primary Organ Systems: Mucosal membranes (oral cavity, esophagus, vagina); gastrointestinal tract; bloodstream; skin and subcutaneous tissues; urinary tract; respiratory system; and potentially any organ in systemic candidiasis
- Common Associated Conditions: Oral candidiasis (thrush); esophageal candidiasis; vaginal yeast infections; invasive candidiasis; candidemia; candidal sepsis; chronic mucocutaneous candidiasis; disseminated candidiasis
- Diseases Diagnosed/Monitored: HIV/AIDS with opportunistic candidiasis; post-transplant candidal infections; neutropenia-associated candidiasis; catheter-associated bloodstream infections; nosocomial (hospital-acquired) candemia; chronic granulomatous disease with candidal complications
- Risk Factors/Associated Conditions: Immunosuppression (HIV, chemotherapy, corticosteroids); prolonged antibiotic therapy; indwelling catheters; diabetes mellitus; malignancy; organ transplantation; broad-spectrum antibiotic use; hospitalization
- Complications of Abnormal Results: Sepsis if bloodstream involved; organ dysfunction from disseminated disease; meningitis if CNS involved; endocarditis with cardiac complications; multi-organ failure in severe systemic candidiasis; chronic nutritional deficiencies from mucosal damage; increased mortality in untreated invasive disease
- Immune System Involvement: Test reflects B-cell and humoral immune response; abnormal results indicate immune system engagement with pathogen; persistent positive results suggest ongoing antigen exposure or impaired clearance; negative results in severely immunocompromised patients may indicate inability to mount immune response
Section 5: Follow-up Tests
- Confirmatory Testing: Blood culture (gold standard for invasive candidiasis); fungal culture from affected site (oral, vaginal, urine); histopathology with fungal staining if tissue samples available; repeat serology if initial results borderline
- Complementary Diagnostic Tests: Candida antigen testing (galactomannan, (1,3)-beta-D-glucan); PCR for Candida detection; complete blood count with differential; metabolic panel; liver and kidney function tests; imaging (CT, ultrasound) for systemic candidiasis localization
- Follow-up Testing Timeline: Borderline results: Repeat serology in 1-2 weeks; Positive acute infection: Retest 2-4 weeks to assess antibody progression; Chronic infection: Monitor every 4-12 weeks depending on clinical response; Post-treatment: Recheck after completion of antifungal therapy to assess antibody decline
- Monitoring During Treatment: Antifungal susceptibility testing if resistance suspected; repeat cultures to confirm organism eradication; monitoring IgM antibody decline as response indicator; CD4 count in HIV patients; liver enzymes if on hepatotoxic antifungals (amphotericin B, azoles)
- Related Tests Providing Complementary Information: Other fungal serology (Aspergillus, Cryptococcus if indicated); CD4 count (immunologic status); inflammatory markers (CRP, ESR); procalcitonin for sepsis assessment; immunoglobulin levels; complement studies
- Further Investigations Based on Results: Positive systemic serology: Abdominal ultrasound or CT for hepatosplenic candidiasis; transthoracic echocardiography for endocarditis assessment; fundoscopic examination for candidal retinitis; lumbar puncture if CNS involvement suspected
Section 6: Fasting Required?
- Fasting Requirement: NO - Fasting is not required for this serologic test
- Food and Beverage: Patient may eat and drink normally; no dietary restrictions; can consume food and beverages up to and including the time of blood draw
- Medications: Continue all regular medications unless otherwise instructed; antifungal medications do not need to be held; inform healthcare provider of current antibiotic or antifungal therapy, as this may affect interpretation
- Patient Preparation: Arrive at lab during normal business hours; bring insurance card and photo ID; inform phlebotomist of medication allergies; inform if taking anticoagulants (warfarin, heparin) for appropriate needle site care; remain seated for 5 minutes before blood draw if feeling lightheaded
- Special Considerations: Hydration recommended to facilitate venipuncture; minimal preparation needed as this is a simple blood test; no specific timing relative to meals; can be drawn at any time of day; no special containers required, standard serum separator tube (SST) used
- Sample Handling: Blood collected via standard venipuncture; serum separated and refrigerated or frozen pending analysis; typically analyzed within 24-48 hours; results usually available within 3-7 business days depending on laboratory

How our test process works!